MACROD1 and rhabdomyosarcoma: CRISPR-mediated MACROD1 knockout rhabdomyosarcoma cells [70] and MACROD1 knockout mice appear viable [71], which makes it unlikely that loss of MACROD1 has a drastic growth inhibitory or developmental effect.